Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Histrelin hydrogel implant: The company completed enrollment in an open-label U.S. Phase III trial of its Histrelin long-acting LHRH hydrogel implant in a total

Hydro Med Sciences Inc., Cranbury, N.J.
Product: Histrelin hydrogel implant
Business: Cancer

Read the full 121 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE